ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 164 filers reported holding ARGENX SE in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,895,086 | +45.5% | 16,059 | +15.3% | 0.00% | +50.0% |
Q2 2023 | $5,427,770 | +6.4% | 13,927 | +1.7% | 0.00% | 0.0% |
Q1 2023 | $5,101,366 | +103355.0% | 13,692 | +5.2% | 0.00% | +100.0% |
Q4 2022 | $4,931 | -99.9% | 13,014 | +19.6% | 0.00% | 0.0% |
Q3 2022 | $3,843,000 | +2.1% | 10,885 | +9.6% | 0.00% | 0.0% |
Q2 2022 | $3,763,000 | +13.9% | 9,932 | -5.2% | 0.00% | 0.0% |
Q1 2022 | $3,305,000 | +80.3% | 10,481 | +100.2% | 0.00% | 0.0% |
Q4 2021 | $1,833,000 | +16.2% | 5,234 | +0.2% | 0.00% | 0.0% |
Q3 2021 | $1,578,000 | -4.8% | 5,226 | -5.1% | 0.00% | 0.0% |
Q2 2021 | $1,658,000 | -20.3% | 5,508 | -27.0% | 0.00% | 0.0% |
Q1 2021 | $2,080,000 | -11.9% | 7,542 | -6.1% | 0.00% | 0.0% |
Q4 2020 | $2,362,000 | +15.4% | 8,030 | +3.0% | 0.00% | 0.0% |
Q3 2020 | $2,047,000 | +33.1% | 7,799 | +14.2% | 0.00% | 0.0% |
Q2 2020 | $1,538,000 | +82.0% | 6,829 | +6.5% | 0.00% | – |
Q1 2020 | $845,000 | -44.3% | 6,412 | -32.1% | 0.00% | -100.0% |
Q4 2019 | $1,517,000 | +40.9% | 9,450 | 0.0% | 0.00% | – |
Q3 2019 | $1,077,000 | -19.5% | 9,450 | 0.0% | 0.00% | -100.0% |
Q2 2019 | $1,338,000 | +13.4% | 9,450 | 0.0% | 0.00% | – |
Q1 2019 | $1,180,000 | +35.3% | 9,450 | +4.1% | 0.00% | – |
Q4 2018 | $872,000 | +50.6% | 9,074 | +19.0% | 0.00% | – |
Q3 2018 | $579,000 | -7.5% | 7,628 | +0.9% | 0.00% | – |
Q2 2018 | $626,000 | +25.7% | 7,559 | +22.1% | 0.00% | – |
Q1 2018 | $498,000 | – | 6,193 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |